Obesity

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

JAMA Netw OpenPublished Predefined secondary analysis of a randomised clinical trial

Authors' conclusion

In this randomized clinical trial, the combination of exercise and GLP-1RA (liraglutide) was the most effective weight loss strategy while preserving bone health. Liraglutide treatment alone reduced BMD at clinically relevant sites more than exercise alone despite similar weight loss.

Study context

Population
Adults aged 18 to 65 years with obesity (BMI 32–43), without diabetes, after an 8-week low-calorie diet (800 kcal/day); Denmark, 2016–2019randomized
Participants
195 adults
Comparison
Exercise alone vs liraglutide alone vs combination vs placebo for 52 weeks after diet-induced weight loss
  • Exercisen = 48
  • Liraglutiden = 49
  • Combinationn = 49
  • Placebon = 49reference
Primary endpoint
Change in site-specific bone mineral density (BMD) at the hip, lumbar spine and distal forearm, measured by DXA in the ITT population
Follow-up
From before the low-calorie diet to end of treatment
Methodological detailsplacebo-controlled, 4-arm, 2-centre (University of Copenhagen and Hvidovre Hospital, Denmark)
  • Placebo-controlled
  • 4-arm
  • 2-centre (University of Copenhagen and Hvidovre Hospital, Denmark)

Primary result

As reported in the abstract

Change in BMD · end of treatment
Mean change, g/cm2 (95% CI)P value
Combinationvs Placebohip; BMD unchanged
−0.006(−0.017 to 0.004)
P = 0.24
Combinationvs Placebolumbar spine; BMD unchanged
−0.010(−0.025 to 0.005)
P = 0.20
Liraglutidevs Exercisehip; BMD decreased with liraglutide
−0.013(−0.024 to −0.001)
P = 0.03
Liraglutidevs Exercisespine; BMD decreased with liraglutide
−0.016(−0.032 to −0.001)
P = 0.04

Further findings

Total estimated mean weight loss during the study

Original publication

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. Published 3 June 2024. doi:10.1001/jamanetworkopen.2024.16775

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.